Cardiff University has recently announced the closure of its Postgraduate Study Zone on Colum Drive. The university has said ...

Their villa at Giverny remained a base of operations throughout their lives. As the century waned, Monet grew bolder: He ...

The federal regulatory agency said it carried out 11 enforcement actions in 2024, levying an average fine of $426 million ...

AstraZeneca is continuing to study AZD8205 as a monotherapy in dose optimization expansion cohorts of patients with ...

Enfortumab vedotin showed a robust disease control rate in patients with urothelial cancer outside of a clinical trial, and ...

The single biggest barrier to HT use, and overall menopause care, is the need for provider training, according to researchers ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that data for the novel, potential ...

ImmVira announced the latest clinical results for its lead oncolytic virus product, MVR-T3011, via intravesical ...

Study Meets Overall Response Rate Primary Endpoint, Encouraging Secondary Endpoint Progression-Free Survival Data in Squamous Cell Carcinoma ...

A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...